{"id":"W2404273804","doi":"10.2337/dc16-0014","title":"Prandial Options to Advance Basal Insulin Glargine Therapy: Testing Lixisenatide Plus Basal Insulin Versus Insulin Glulisine Either as Basal-Plus or Basal-Bolus in Type 2 Diabetes: The GetGoal Duo-2 Trial","year":2016,"lang":"en","type":"article","venue":"Diabetes Care","topic":"Diabetes Management and Research","field":"Medicine","cited_by":131,"is_retracted":false,"has_abstract":true,"ca_institutions":"LMC Diabetes & Endocrinology (Canada)","funders":"Sanofi","keywords":"Lixisenatide; Medicine; Insulin glargine; Metformin; Postprandial; Internal medicine; Type 2 diabetes; Endocrinology; Diabetes mellitus; Hypoglycemia; Insulin; Exenatide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002431601,0.001461864,0.002402221,0.0003009341,0.0002130931,0.001175761,0.0006726864,0.001341193,0.006031901],"category_scores_gemma":[0.001975353,0.0004852502,0.002597826,0.0002925899,0.0008074424,0.001198038,0.0006970094,0.003025865,0.0006104879],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004862774,"about_ca_system_score_gemma":0.0007959513,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004987711,"about_ca_topic_score_gemma":0.001112082,"domain_scores_codex":[0.9991906,0.0004924031,0.00005573954,0.0001037291,0.00006846717,0.00008899425],"domain_scores_gemma":[0.9991869,0.0002930028,0.0001952985,0.00007439827,0.00003697093,0.0002133805],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9737074,0.004080054,0.0006578399,0.0009089691,0.001287177,0.00002215642,0.00003689929,0.0003872743,0.001074712,0.0001087131,0.0003430389,0.01738578],"study_design_scores_gemma":[0.9121996,0.0817138,0.002284392,0.0001352488,0.001607744,0.00003430185,0.00003023164,0.0004631004,0.0005534189,0.0002159898,0.0007438487,0.0000184022],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9811329,0.01075312,0.0006800704,0.00107853,0.0003695408,0.001694666,0.0008090309,0.00009520254,0.00338679],"genre_scores_gemma":[0.9843785,0.005295159,0.002453934,0.001708294,0.0003835645,0.002118621,0.001099608,0.0000275122,0.002534868],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006031901,"threshold_uncertainty_score":0.02017874,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04099367259727368,"score_gpt":0.3202192885146405,"score_spread":0.2792256159173668,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}